Search research articles
Contact Us
Filters
Showing results (251-260 of 269) with videos related to
Page
of 27
Sort By:
Cellular Immunology
|
August 1, 1989
Regulation of Fc epsilon receptor 2 (CD23) expression on a human eosinophilic cell line EoL3 and a human monocytic cell line U937 by transforming growth factor beta
M Tanaka, K C Lee, J Yodoi, et al.
Thorax
|
April 8, 2006
Extracellular thioredoxin levels are increased in patients with acute lung injury
M E Callister, A Burke-Gaffney, G J Quinlan, et al.
Immunology Letters
|
September 1, 1990
Transforming growth factor beta and dexamethasone suppress the expression of Fc epsilon receptor 2 (CD23) on a human eosinophilic cell line EoL-3
H Watanabe, T Kawabe, J Yodoi, et al.
The Journal of Biological Chemistry
|
December 10, 1999
Thioredoxin-dependent redox regulation of p53-mediated p21 activation
M Ueno, H Masutani, R J Arai, et al.
International Immunology
|
May 1, 1995
Activation of natural killer cells by the mAb YTA-1 that recognizes leukocyte function-associated antigen-1
K Sugie, K Nakamura, K Teshigawara, et al.
The Journal of Biological Chemistry
|
February 10, 1995
Upstream mechanisms of glycogen synthase activation by insulin and insulin-like growth factor-I. Glycogen synthase activation is antagonized by wortmannin or LY294002 but not by rapamycin or by inhibiting p21ras
R Yamamoto-Honda, K Tobe, Y Kaburagi, et al.
Diabetologia
|
June 1, 2010
Transgenic mice overproducing human thioredoxin-1, an antioxidative and anti-apoptotic protein, prevents diabetic embryopathy
Y Kamimoto, T Sugiyama, T Kihira, et al.
Oncogene
|
July 6, 2001
Thioredoxin participates in a cell death pathway induced by interferon and retinoid combination
X Ma, S Karra, D J Lindner, et al.
Journal of Hepatology
|
November 4, 2000
Serum thioredoxin levels as an indicator of oxidative stress in patients with hepatitis C virus infection
Y Sumida, T Nakashima, T Yoh, et al.
International Journal of Clinical Pharmacology and Therapeutics
|
August 28, 2003
Effects of transdermal and oral estrogen supplementation on endothelial function, inflammation and cellular redox state
H Kawano, H Yasue, N Hirai, et al.
Page
of 27
Search research articles
Search
Showing results (251-260 of 269) with videos related to
Sort By:
Page
of 27
Cellular Immunology
|
August 1, 1989
Regulation of Fc epsilon receptor 2 (CD23) expression on a human eosinophilic cell line EoL3 and a human monocytic cell line U937 by transforming growth factor beta
M Tanaka, K C Lee, J Yodoi, et al.
Thorax
|
April 8, 2006
Extracellular thioredoxin levels are increased in patients with acute lung injury
M E Callister, A Burke-Gaffney, G J Quinlan, et al.
Immunology Letters
|
September 1, 1990
Transforming growth factor beta and dexamethasone suppress the expression of Fc epsilon receptor 2 (CD23) on a human eosinophilic cell line EoL-3
H Watanabe, T Kawabe, J Yodoi, et al.
The Journal of Biological Chemistry
|
December 10, 1999
Thioredoxin-dependent redox regulation of p53-mediated p21 activation
M Ueno, H Masutani, R J Arai, et al.
International Immunology
|
May 1, 1995
Activation of natural killer cells by the mAb YTA-1 that recognizes leukocyte function-associated antigen-1
K Sugie, K Nakamura, K Teshigawara, et al.
The Journal of Biological Chemistry
|
February 10, 1995
Upstream mechanisms of glycogen synthase activation by insulin and insulin-like growth factor-I. Glycogen synthase activation is antagonized by wortmannin or LY294002 but not by rapamycin or by inhibiting p21ras
R Yamamoto-Honda, K Tobe, Y Kaburagi, et al.
Diabetologia
|
June 1, 2010
Transgenic mice overproducing human thioredoxin-1, an antioxidative and anti-apoptotic protein, prevents diabetic embryopathy
Y Kamimoto, T Sugiyama, T Kihira, et al.
Oncogene
|
July 6, 2001
Thioredoxin participates in a cell death pathway induced by interferon and retinoid combination
X Ma, S Karra, D J Lindner, et al.
Journal of Hepatology
|
November 4, 2000
Serum thioredoxin levels as an indicator of oxidative stress in patients with hepatitis C virus infection
Y Sumida, T Nakashima, T Yoh, et al.
International Journal of Clinical Pharmacology and Therapeutics
|
August 28, 2003
Effects of transdermal and oral estrogen supplementation on endothelial function, inflammation and cellular redox state
H Kawano, H Yasue, N Hirai, et al.
Page
of 27